These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11462957)

  • 1. [Relationship between lymphatic metastasis in breast and cervix cancers and the level of CD44-H expression evaluated by an immunohistochemical method].
    Yahyaoui O; Guerbaoui M; Oudghiri M
    Gynecol Obstet Fertil; 2001 Jun; 29(6):422-6. PubMed ID: 11462957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of variant exon v7-v8 CD44 antigen in relation to lymphatic metastasis of human breast cancer.
    Kinoshita J; Haga S; Shimizu T; Imamura H; Watanabe O; Kajiwara T
    Breast Cancer Res Treat; 1999 Jan; 53(2):177-83. PubMed ID: 10326795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44+/CD24- cells and lymph node metastasis in stage I and II invasive ductal carcinoma of the breast.
    Tiezzi DG; Valejo FA; Marana HR; Carrara HH; Benevides L; Antonio HM; Sicchieri RD; Milanezi CM; Silva JS; de Andrade JM
    Med Oncol; 2012 Sep; 29(3):1479-85. PubMed ID: 21713550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44.
    Sinn HP; Heider KH; Skroch-Angel P; von Minckwitz G; Kaufmann M; Herrlich P; Ponta H
    Breast Cancer Res Treat; 1995; 36(3):307-313. PubMed ID: 8573713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A CD44 variant exon 6 epitope as a prognostic indicator in breast cancer.
    Schumacher U; Horny HP; Horst HA; Herrlich P; Kaiserling E
    Eur J Surg Oncol; 1996 Jun; 22(3):259-61. PubMed ID: 8654608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.
    Chen Y; Song J; Jiang Y; Yu C; Ma Z
    Int J Clin Exp Pathol; 2015; 8(9):11287-95. PubMed ID: 26617852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of angiogenesis, laminin and CD44 expression in metastatic behavior of early-stage low-grade invasive breast carcinomas.
    Ozer E; Canda T; Kurtodlu B
    Cancer Lett; 1997 Dec; 121(2):119-23. PubMed ID: 9570348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of CD44 in nonpalpable T1a and T1b breast cancer.
    Lyzak JS; Yaremko ML; Recant W; Baunoch DA; Joseph L
    Hum Pathol; 1997 Jul; 28(7):772-8. PubMed ID: 9224743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined detection of Twist1, Snail1 and squamous cell carcinoma antigen for the prognostic evaluation of invasion and metastasis in cervical squamous cell carcinoma.
    Yang H; Hu H; Gou Y; Hu Y; Li H; Zhao H; Wang B; Li P; Zhang Z
    Int J Clin Oncol; 2018 Apr; 23(2):321-328. PubMed ID: 29101499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix].
    Li Q; Liu S; Liu H; Zhang J; Guo S; Wang L
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):131-6. PubMed ID: 25877611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of CD44 variant v6 in breast carcinoma and its relationship with other parameters of tumor biology].
    Aceituno E; Turrión F; San Román JM; Sarasa JL; Ortiz F; García R
    Med Clin (Barc); 1998 Jul; 111(5):168-71. PubMed ID: 9732832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CD44 isoforms in infiltrating lobular carcinoma of the breast.
    Berner HS; Nesland JM
    Breast Cancer Res Treat; 2001 Jan; 65(1):23-9. PubMed ID: 11245336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the CD44 variant isoforms 6 and 4/5 in breast cancer. Correlation with established prognostic parameters.
    Regidor PA; Callies R; Regidor M; Günthert U; Zöller M; Schindler AE
    Arch Gynecol Obstet; 1996; 258(3):125-35. PubMed ID: 8781700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44v3 and VEGF-C expression and its relationship with lymph node metastasis in squamous cell carcinomas of the uterine cervix.
    Liu YQ; Li HF; Han JJ; Tang QL; Sun Q; Huang ZQ; Li HG
    Asian Pac J Cancer Prev; 2014; 15(12):5049-53. PubMed ID: 24998585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression patterns of standard and variant CD44 molecules in normal uterine cervix and cervical cancer.
    Shimabukuro K; Toyama-Sorimachi N; Ozaki Y; Goi T; Furukawa K; Miyasaka M; Aso T
    Gynecol Oncol; 1997 Jan; 64(1):26-34. PubMed ID: 8995543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulated expression of CD44 variant 6 in oral squamous cell carcinomas and its relationship to regional lymph node metastasis.
    Kunishi M; Kayada Y; Yoshiga K
    Int J Oral Maxillofac Surg; 1997 Aug; 26(4):280-3. PubMed ID: 9258720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of standard type of CD44 expression in invaded area as a good indicator of lymph-node metastasis in colorectal carcinoma.
    Asao T; Nakamura J; Shitara Y; Tsutsumi S; Mochiki E; Shimura T; Takenoshita S; Kuwano H
    Dis Colon Rectum; 2000 Sep; 43(9):1250-4; discussion 1254-5. PubMed ID: 11005492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinicopathological significance of CD44+/CD24-/low and CD24+ tumor cells in invasive micropapillary carcinoma of the breast.
    Li W; Liu F; Lei T; Xu X; Liu B; Cui L; Wei J; Guo X; Lang R; Fan Y; Gu F; Tang P; Zhang X; Fu L
    Pathol Res Pract; 2010 Dec; 206(12):828-34. PubMed ID: 20977976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of MMP9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication.
    Yu W; Liu J; Xiong X; Ai Y; Wang H
    Pathol Res Pract; 2009; 205(10):709-15. PubMed ID: 19541433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD44 and ALDH1 immunoexpression as prognostic indicators of invasion and metastasis in oral squamous cell carcinoma.
    Ortiz RC; Lopes NM; Amôr NG; Ponce JB; Schmerling CK; Lara VS; Moyses RA; Rodini CO
    J Oral Pathol Med; 2018 Sep; 47(8):740-747. PubMed ID: 29791975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.